Syneos Health Stock

Syneos Health ROCE 2024

Syneos Health ROCE

0.13

Ticker

SYNH

ISIN

US87166B1026

WKN

A2JBKW

In 2024, Syneos Health's return on capital employed (ROCE) was 0.13, a 8.95% increase from the 0.12 ROCE in the previous year.

Syneos Health Aktienanalyse

What does Syneos Health do?

Syneos Health is a US-based pharmaceutical and biotech service company. They specialize in providing integrated solutions for clinical research, commercial services, and data analysis. The company was founded in 2017 through the merger of two leading service companies, INC Research and inVentiv Health. Today, Syneos Health is one of the largest providers of clinical and commercial services in the pharmaceutical and biotech industry. They support their customers in the development and marketing of medications, diagnostics, and medical devices by offering a wide range of services including planning and conducting clinical trials, data analysis and management, and product marketing. Syneos Health operates in four business areas: clinical solutions, commercial solutions, consulting services, and clinical data analysis. Their primary focus is on delivering customer-centric services that cover various aspects of the pharmaceutical and biotech industry value chain. Within their clinical and medical segment, they conduct clinical trials and provide supporting services. They have expertise in clinical research and have successfully executed numerous studies. Syneos Health also offers consulting services in the areas of data management systems and clinical trials. In the commercial segment, they assist customers with marketing, sales promotion, and channel management to ensure the successful launch and sales of products. They provide training for sales staff, market research and analysis, and continuous support from sales and marketing experts. Their consulting services encompass strategy consulting, market research, branding, and communication. They also assist with the development, implementation, and validation of clinical trials, literature research, and regulatory support. Syneos Health's clinical data analysis involves analyzing large data sets to gain insights into the healthcare industry. They utilize cutting-edge technologies such as Big Data Analytics and Machine Learning to provide customers with valuable insights that aid in decision-making. In addition to clinical trials and consulting, Syneos Health offers modern technologies for the development and marketing of medications. This includes Virtual Reality solutions, personalized patient programs for chronic disease treatment, and digital platforms for data collection, analysis, and management. Syneos Health serves globally operating pharmaceutical and biotech companies that rely on their services to develop and market innovative medications and treatment methods. Customers value Syneos Health's expertise and trust that the company will help them successfully bring their products to market. Overall, Syneos Health is a leading company in the pharmaceutical and biotech industry. Their integrated services enable customers to work faster and more effectively. By combining expertise in clinical research, commercial solutions, consulting services, and clinical data analysis, Syneos Health offers innovative and successful solutions to its customers. Syneos Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Syneos Health's Return on Capital Employed (ROCE)

Syneos Health's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Syneos Health's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Syneos Health's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Syneos Health’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Syneos Health stock

What is the ROCE (Return on Capital Employed) of Syneos Health this year?

The ROCE of Syneos Health is 0.13 undefined this year.

How has the ROCE (Return on Capital Employed) of Syneos Health developed compared to the previous year?

The ROCE of Syneos Health has increased by 8.95% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Syneos Health?

A high Return on Capital Employed (ROCE) indicates that Syneos Health has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Syneos Health?

A low ROCE (Return on Capital Employed) can indicate that Syneos Health has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Syneos Health impact the company?

An increase in the ROCE of Syneos Health can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Syneos Health affect the company?

A decrease in ROCE of Syneos Health can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Syneos Health?

Some factors that can affect Syneos Health's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Syneos Health so important for investors?

The ROCE of Syneos Health is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Syneos Health take to improve the ROCE?

To improve the ROCE, Syneos Health can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Syneos Health pay?

Over the past 12 months, Syneos Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Syneos Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Syneos Health?

The current dividend yield of Syneos Health is .

When does Syneos Health pay dividends?

Syneos Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Syneos Health?

Syneos Health paid dividends every year for the past 0 years.

What is the dividend of Syneos Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Syneos Health located?

Syneos Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Syneos Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Syneos Health from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Syneos Health pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Syneos Health in the year 2023?

In the year 2023, Syneos Health distributed 0 USD as dividends.

In which currency does Syneos Health pay out the dividend?

The dividends of Syneos Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Syneos Health

Our stock analysis for Syneos Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Syneos Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.